COCP
Cocrystal Pharma·NASDAQ
--
--(--)
--
--(--)
COCP fundamentals
Cocrystal Pharma (COCP) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.2 (YoY +62.26%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.2
+62.26%
Report date
Aug 14, 2025
EPS
Actual | -0.24 | -0.48 | -0.48 | -0.48 | -0.48 | -0.48 | -3 | -0.7 | -0.59 | -0.64 | -0.5 | -0.41 | -0.32 | -0.39 | -0.53 | -0.49 | -0.31 | -0.23 | -0.2 | |||||
Forecast | -0.48 | -0.48 | -0.54 | -0.42 | -0.48 | -0.48 | -0.42 | -0.52 | -0.4867 | -0.7267 | -0.6 | -0.58 | -0.53 | -0.5967 | -0.54 | -0.4767 | -0.57 | -0.53 | -0.505 | -0.23 | ||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +50.00% | +11.11% | -14.29% | 0.00% | 0.00% | -14.29% | -476.92% | -43.83% | +18.81% | -6.67% | +13.79% | +22.64% | +46.37% | +27.78% | -11.18% | +14.04% | +41.51% | +54.46% | +13.04% |
Revenue
Actual | -- | -- | -- | -- | -- | 515.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | 500.00K | 580.00K | 550.00K | 275.00K | 275.00K | 0 | 625.00K | 83.33K | 83.33K | 0 | 166.67K | 266.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11.21% | -100.00% | -100.00% | -100.00% | 0.00% | -100.00% | -100.00% | -100.00% | 0.00% | -100.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Cocrystal Pharma's earnings call?Did Cocrystal Pharma beat or miss consensus estimates last quarter?What does Cocrystal Pharma do and what are its main business segments?What were the key takeaways from Cocrystal Pharma’s earnings call?What factors drove the changes in Cocrystal Pharma's revenue and profit?What guidance did Cocrystal Pharma's management provide for the next earnings period?What is the revenue and EPS growth rate for Cocrystal Pharma year over year?What is the market's earnings forecast for Cocrystal Pharma next quarter?
